RUCAPARIB vs RUXOLITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RUCAPARIB vs RUXOLITINIB: Safety Overview
| Metric | RUCAPARIB | RUXOLITINIB |
|---|---|---|
| Total FAERS Reports | 434 | 68,133 |
| Deaths Reported | 50 | 10,908 |
| Death Rate | 11.5% | 16.0% |
| Hospitalizations | 310 | 14,461 |
| Average Patient Age | 64.3 yrs | 59.7 yrs |
| % Female Patients | 69.5% | 48.8% |
| FDA Approval Date | N/A | Nov 16, 2011 |
| Manufacturer | N/A | Incyte Corporation |
| Route | N/A | TOPICAL |
| Marketing Status | N/A | Prescription |